Oral Glucose Tolerance Test Predicts Episodic Memory Decline: A 10-Year Population-Based Follow-up Study

被引:6
作者
Toppala, Sini [1 ,2 ,3 ]
Ekblad, Laura L. [1 ,2 ,4 ]
Viitanen, Matti [4 ,5 ,6 ]
Rinne, Juha O. [1 ,2 ]
Jula, Antti [2 ,7 ]
机构
[1] Univ Turku, Turku PET Ctr, Turku, Finland
[2] Turku Univ Hosp, Turku PET Ctr, Turku, Finland
[3] Kuopio City Home Care Rehabil & Med Serv Elderly, Kuopio, Finland
[4] Turku City Hosp, Welf Div, City Turku, Turku, Finland
[5] Univ Turku, Turku City Hosp, Dept Geriatr, Turku, Finland
[6] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
[7] Natl Inst Hlth & Welf, Turku, Finland
基金
芬兰科学院;
关键词
ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; INSULIN-RESISTANCE; DEMENTIA;
D O I
10.2337/dc21-0042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To examine if the 2-h value of an oral glucose tolerance test (OGTT) can predict cognitive decline. RESEARCH DESIGN AND METHODS This study is based on a subpopulation of the Finnish population-based Health 2000 Survey and its follow-up, the Health 2011 study. Altogether, 961 individuals aged 45-74 (mean 55.6 years; 55.8% women) underwent OGTT in 2001-2002. Categorical verbal fluency, word-list learning, and word-list delayed recall were tested at baseline and at follow-up in 2011. Statistical analyses were performed with multivariable linear models adjusted for previously reported risk factors for cognitive decline. RESULTS A higher 2-h glucose value in the OGTT at baseline predicted worse performance (slope: -0.08; P = 0.01) and greater decline (slope: -0.07; P = 0.007) in the word-list delayed recall test after 10 years. CONCLUSIONS Our results indicate that higher 2-h glucose values in the OGTT predict a decline in episodic memory after 10 years.
引用
收藏
页码:2435 / 2437
页数:3
相关论文
共 15 条
[1]  
Aromaa A., 2004, Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey
[2]   Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions [J].
Biessels, Geert Jan ;
Strachan, Mark W. J. ;
Visseren, Frank L. J. ;
Kappelle, L. Jaap ;
Whitmer, Rachel A. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (03) :246-255
[3]   Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation [J].
Ekblad, Laura L. ;
Johansson, Jarkko ;
Helin, Semi ;
Viitanen, Matti ;
Laine, Hanna ;
Puukka, Pauli ;
Jula, Antti ;
Rinne, Juha O. .
NEUROLOGY, 2018, 90 (13) :E1150-+
[4]   Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample [J].
Ekblad, Laura L. ;
Rinne, Juha O. ;
Puukka, Pauli ;
Laine, Hanna ;
Ahtiluoto, Satu ;
Sulkava, Raimo ;
Viitanen, Matti ;
Jula, Antti .
DIABETES CARE, 2017, 40 (06) :751-758
[5]  
Heistaro S., 2008, Methodology Report: Health 2000 Survey
[6]   Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade [J].
Jack, Clifford R., Jr. ;
Knopman, David S. ;
Jagust, William J. ;
Shaw, Leslie M. ;
Aisen, Paul S. ;
Weiner, Michael W. ;
Petersen, Ronald C. ;
Trojanowski, John Q. .
LANCET NEUROLOGY, 2010, 9 (01) :119-128
[7]   Change in cognitive function by glucose tolerance status in older adults - A 4-year prospective study of the Rancho Bernardo Study Cohort [J].
Kanaya, AM ;
Barrett-Connor, E ;
Gildengorin, G ;
Yaffe, K .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (12) :1327-1333
[8]   Diabetes and cognitive function in a middle-aged cohort - Findings from the Whitehall II study [J].
Kumari, M ;
Marmot, M .
NEUROLOGY, 2005, 65 (10) :1597-1603
[9]  
Lundqvist A, 2016, HLTH 2011 SURVEY MET
[10]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .1. CLINICAL AND NEUROPSYCHOLOGICAL ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MORRIS, JC ;
HEYMAN, A ;
MOHS, RC ;
HUGHES, JP ;
VANBELLE, G ;
FILLENBAUM, G ;
MELLITS, ED ;
CLARK, C .
NEUROLOGY, 1989, 39 (09) :1159-1165